on September 17, 2026 at 10:47 am Tata Sons IPO order backs Shapoorji Pallonji’s long-running ask​
finance, Uncategorized

on September 17, 2026 at 10:47 am Tata Sons IPO order backs Shapoorji Pallonji’s long-running ask​

on September 17, 2026 at 10:47 am Tata Sons IPO order backs Shapoorji Pallonji’s long-running ask​

Executives close to Shapoorji Pallonji Group are said to have held meetings with government officials in recent months to press their case for a Tata Sons listing.

Executives close to Shapoorji Pallonji Group are said to have held meetings with government officials in recent months to press their case for a Tata Sons listing.

on September 17, 2026 at 10:44 am RBI listing, N Chandrasekaran’s decision on agenda: What’s in store as Tata Sons meet today?​
finance, Uncategorized

on September 17, 2026 at 10:44 am RBI listing, N Chandrasekaran’s decision on agenda: What’s in store as Tata Sons meet today?​

on September 17, 2026 at 10:44 am RBI listing, N Chandrasekaran’s decision on agenda: What’s in store as Tata Sons meet today?​

Tata Sons board meeting on Thursday will address the RBI’s public listing mandate and outgoing Chairman Natarajan Chandrasekaran’s resignation. Friction with Tata Trusts Chairman Noel Tata over listing issues has led to tensions within the board.

Tata Sons board meeting on Thursday will address the RBI’s public listing mandate and outgoing Chairman Natarajan Chandrasekaran’s resignation. Friction with Tata Trusts Chairman Noel Tata over listing issues has led to tensions within the board.

on September 17, 2026 at 10:30 am Pine Labs share price jumps 5%: Why new UPI MDR rules could boost earnings – Check new target​
finance, Uncategorized

on September 17, 2026 at 10:30 am Pine Labs share price jumps 5%: Why new UPI MDR rules could boost earnings – Check new target​

on September 17, 2026 at 10:30 am Pine Labs share price jumps 5%: Why new UPI MDR rules could boost earnings – Check new target​

With a shift to a recurring revenue model from the new UPI framework, Pine Labs could see a 20% EBIT increase. Following NPCI’s MDR implementation, the company’s stock has risen 5%.

With a shift to a recurring revenue model from the new UPI framework, Pine Labs could see a 20% EBIT increase. Following NPCI’s MDR implementation, the company’s stock has risen 5%.

Scroll to Top